Leaving the EU with a deal remains the Government’s top priority. This has not changed. However a responsible government must plan for every eventuality, including a no deal scenario. We are intensifying and accelerating no deal planning to ensure we are fully prepared.
This guidance follows on from the further guidance note published on 3 January 2019.
This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.
NIBSC is a world leader in the production and distribution of biological reference materials and standards, including WHO International Standards, for use in the quality assurance of biological medicines. Following the UK’s exit from the EU, NIBSC’s commitment to public health and global harmonisation of biological medicines will remain unchanged.
NIBSC has reviewed the situation with regards to continuity of supply of our products, should the UK leave the EU without a deal.
International standards and other biological reference materials supplied by NIBSC are, with a few exceptions, currently made, stored and distributed from our site in South Mimms, in the UK.
This means that if your delivery address is in the UK there will be no changes to delivery arrangements should there be a no deal scenario.
NIBSC has a long-established record of distributing biological standards and reference materials globally and our products are typically shipped by airfreight. Therefore, we don’t anticipate significant difficulties in the supply of our products in Europe or elsewhere in the world should the UK leave the EU without a deal.
You may also want to look at the guidance for businesses, issued by the government.
This page will be updated as new information becomes available.
Please contact us at firstname.lastname@example.org if you require any further information.